We use cookies on this site. By browsing our site you agree to our use of cookies. Close this message Find out more

Home > School Seminar - Dr Ben Whalley
More in this section Previous Years

School Seminar - Dr Ben Whalley

Date(s)
22/01/2014 (16:05-17:00)
Description
Ben Whalley

Dr Ben Whalley

Dr Ben Whalley
Reading School of Pharmacy
University of Reading

Host - Prof Robin Williams

The use of cannabis for the treatment of a variety of disorders has been advocated for many centuries but the number of licensed medicines based on cannabinoids remains small and the clinical evidence base limited. In recent years, the use of cannabis for the treatment of epilepsy has received considerable scientific and popular attention due to new preclinical study results and decriminalisation of cannabis use in some US states.

Whilst the former has resulted in the first formal clinical trials for cannabis components in epilepsy, the latter has triggered a surge in the use of herbal cannabis without regulation for the treatment of childhood epilepsies.

My talk will consider the historical background to the use of non-psychoactive cannabinoids in epilepsy, present our preclinical results for their use against seizures and discuss the risks presented by unregulated use of psychoactive cannabinoids in epilepsy using evidence of the diverse pharmacology of cannabis constituents.

 


   
 
 
 

Comment on this page

Did you find the information you were looking for? Is there a broken link or content that needs updating? Let us know so we can improve the page.

Note: If you need further information or have a question that cannot be satisfied by this page, please call our switchboard on +44 (0)1784 434455.

This window will close when you submit your comment.

Add Your Feedback
Close